{"id": "test_8_0", "text": "In @DISEASE$ patients, TLR-induced GM-CSF secretion was impaired by both @GENE$-dependent and -independent mechanisms.", "text_with_entity_marker": "In [E1]@DISEASE$[/E1] patients, TLR-induced GM-CSF secretion was impaired by both [E2]@GENE$[/E2]-dependent and -independent mechanisms.", "text_with_typed_entity_marker": "In [DISEASE]@DISEASE$[/DISEASE] patients, TLR-induced GM-CSF secretion was impaired by both [GENE]@GENE$[/GENE]-dependent and -independent mechanisms.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [3, 12], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 21], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [73, 79], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_idx_in_text_with_typed_entity_marker": [98, 104], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_1", "text": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of @DISEASE$ and is consistent with the hypothesis that impaired @GENE$ secretion in part constitutes a NOD2-dependent disease risk factor.", "text_with_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [E1]@DISEASE$[/E1] and is consistent with the hypothesis that impaired [E2]@GENE$[/E2] secretion in part constitutes a NOD2-dependent disease risk factor.", "text_with_typed_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [DISEASE]@DISEASE$[/DISEASE] and is consistent with the hypothesis that impaired [GENE]@GENE$[/GENE] secretion in part constitutes a NOD2-dependent disease risk factor.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [95, 104], "entity_1_idx_in_text_with_entity_marker": [99, 108], "entity_1_idx_in_text_with_typed_entity_marker": [104, 113], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [157, 163], "entity_2_idx_in_text_with_entity_marker": [170, 176], "entity_2_idx_in_text_with_typed_entity_marker": [182, 188], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_2", "text": "Based on @GENE$ analyses, 41 @DISEASE$ patients and 12 healthy controls were studied.", "text_with_entity_marker": "Based on [E1]@GENE$[/E1] analyses, 41 [E2]@DISEASE$[/E2] patients and 12 healthy controls were studied.", "text_with_typed_entity_marker": "Based on [GENE]@GENE$[/GENE] analyses, 41 [DISEASE]@DISEASE$[/DISEASE] patients and 12 healthy controls were studied.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [9, 15], "entity_1_idx_in_text_with_entity_marker": [13, 19], "entity_1_idx_in_text_with_typed_entity_marker": [15, 21], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [29, 38], "entity_2_idx_in_text_with_entity_marker": [42, 51], "entity_2_idx_in_text_with_typed_entity_marker": [51, 60], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_3", "text": "Moreover, TNF-alpha production was induced by a @GENE$-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in @DISEASE$ patients.", "text_with_entity_marker": "Moreover, TNF-alpha production was induced by a [E1]@GENE$[/E1]-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "Moreover, TNF-alpha production was induced by a [GENE]@GENE$[/GENE]-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [165, 174], "entity_2_idx_in_text_with_entity_marker": [178, 187], "entity_2_idx_in_text_with_typed_entity_marker": [187, 196], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_4", "text": "@DISEASE$ patients have impaired @GENE$ secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients have impaired [E2]@GENE$[/E2] secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients have impaired [GENE]@GENE$[/GENE] secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [33, 39], "entity_2_idx_in_text_with_entity_marker": [46, 52], "entity_2_idx_in_text_with_typed_entity_marker": [58, 64], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_5", "text": "@DISEASE$ patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of @GENE$ secretion.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of [E2]@GENE$[/E2] secretion.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of [GENE]@GENE$[/GENE] secretion.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [153, 159], "entity_2_idx_in_text_with_entity_marker": [166, 172], "entity_2_idx_in_text_with_typed_entity_marker": [178, 184], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_6", "text": "@DISEASE$ patients with NOD2 mutations were able to secrete TNF-alpha, but not @GENE$, upon stimulation with NOD2 and TLR-7 ligands.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients with NOD2 mutations were able to secrete TNF-alpha, but not [E2]@GENE$[/E2], upon stimulation with NOD2 and TLR-7 ligands.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients with NOD2 mutations were able to secrete TNF-alpha, but not [GENE]@GENE$[/GENE], upon stimulation with NOD2 and TLR-7 ligands.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [79, 85], "entity_2_idx_in_text_with_entity_marker": [92, 98], "entity_2_idx_in_text_with_typed_entity_marker": [104, 110], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_7", "text": "In @DISEASE$ patients, TLR-induced @GENE$ secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_entity_marker": "In [E1]@DISEASE$[/E1] patients, TLR-induced [E2]@GENE$[/E2] secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_typed_entity_marker": "In [DISEASE]@DISEASE$[/DISEASE] patients, TLR-induced [GENE]@GENE$[/GENE] secretion was impaired by both NOD2-dependent and -independent mechanisms.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [3, 12], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 21], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [35, 41], "entity_2_idx_in_text_with_entity_marker": [48, 54], "entity_2_idx_in_text_with_typed_entity_marker": [60, 66], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_8", "text": "Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in @DISEASE$ by @GENE$-dependent and -independent pathways.", "text_with_entity_marker": "Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in [E1]@DISEASE$[/E1] by [E2]@GENE$[/E2]-dependent and -independent pathways.", "text_with_typed_entity_marker": "Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in [DISEASE]@DISEASE$[/DISEASE] by [GENE]@GENE$[/GENE]-dependent and -independent pathways.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [101, 110], "entity_1_idx_in_text_with_entity_marker": [105, 114], "entity_1_idx_in_text_with_typed_entity_marker": [110, 119], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [114, 120], "entity_2_idx_in_text_with_entity_marker": [127, 133], "entity_2_idx_in_text_with_typed_entity_marker": [139, 145], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_9", "text": "Elevation of @GENE$ expression in @DISEASE$ with Gsalpha protein mutation.", "text_with_entity_marker": "Elevation of [E1]@GENE$[/E1] expression in [E2]@DISEASE$[/E2] with Gsalpha protein mutation.", "text_with_typed_entity_marker": "Elevation of [GENE]@GENE$[/GENE] expression in [DISEASE]@DISEASE$[/DISEASE] with Gsalpha protein mutation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [13, 19], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_idx_in_text_with_typed_entity_marker": [19, 25], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [34, 43], "entity_2_idx_in_text_with_entity_marker": [47, 56], "entity_2_idx_in_text_with_typed_entity_marker": [56, 65], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_10", "text": "The expression of @GENE$ (GHRHR) is regulated by GHRH, both of which are known to be expressed in human @DISEASE$ cells.", "text_with_entity_marker": "The expression of [E1]@GENE$[/E1] (GHRHR) is regulated by GHRH, both of which are known to be expressed in human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "The expression of [GENE]@GENE$[/GENE] (GHRHR) is regulated by GHRH, both of which are known to be expressed in human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [104, 113], "entity_2_idx_in_text_with_entity_marker": [117, 126], "entity_2_idx_in_text_with_typed_entity_marker": [126, 135], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_11", "text": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in @DISEASE$ cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of @GENE$ signaling.", "text_with_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [E1]@DISEASE$[/E1] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of [E2]@GENE$[/E2] signaling.", "text_with_typed_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [DISEASE]@DISEASE$[/DISEASE] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of [GENE]@GENE$[/GENE] signaling.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [78, 87], "entity_1_idx_in_text_with_entity_marker": [82, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 96], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [236, 242], "entity_2_idx_in_text_with_entity_marker": [249, 255], "entity_2_idx_in_text_with_typed_entity_marker": [261, 267], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_12", "text": "The expression of GHRH receptor (GHRHR) is regulated by @GENE$, both of which are known to be expressed in human @DISEASE$ cells.", "text_with_entity_marker": "The expression of GHRH receptor (GHRHR) is regulated by [E1]@GENE$[/E1], both of which are known to be expressed in human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "The expression of GHRH receptor (GHRHR) is regulated by [GENE]@GENE$[/GENE], both of which are known to be expressed in human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [113, 122], "entity_2_idx_in_text_with_entity_marker": [126, 135], "entity_2_idx_in_text_with_typed_entity_marker": [135, 144], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_13", "text": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in @DISEASE$ cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their @GENE$ expression probably because of their saturation of GHRH signaling.", "text_with_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [E1]@DISEASE$[/E1] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their [E2]@GENE$[/E2] expression probably because of their saturation of GHRH signaling.", "text_with_typed_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [DISEASE]@DISEASE$[/DISEASE] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their [GENE]@GENE$[/GENE] expression probably because of their saturation of GHRH signaling.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [78, 87], "entity_1_idx_in_text_with_entity_marker": [82, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 96], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [174, 180], "entity_2_idx_in_text_with_entity_marker": [187, 193], "entity_2_idx_in_text_with_typed_entity_marker": [199, 205], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_14", "text": "@GENE$ play crucial roles in DNA replication and @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] play crucial roles in DNA replication and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] play crucial roles in DNA replication and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [49, 58], "entity_2_idx_in_text_with_entity_marker": [62, 71], "entity_2_idx_in_text_with_typed_entity_marker": [71, 80], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_15", "text": "Our data provide the first evidence that the @GENE$ polymorphism is associated with decreased risk of @DISEASE$.", "text_with_entity_marker": "Our data provide the first evidence that the [E1]@GENE$[/E1] polymorphism is associated with decreased risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Our data provide the first evidence that the [GENE]@GENE$[/GENE] polymorphism is associated with decreased risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [102, 111], "entity_2_idx_in_text_with_entity_marker": [115, 124], "entity_2_idx_in_text_with_typed_entity_marker": [124, 133], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_16", "text": "To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of @GENE$ and VEGFR-1 by immunohistochemistry.", "text_with_entity_marker": "To assess clinical significance, 93 [E1]@DISEASE$[/E1] lesions were evaluated for expression of [E2]@GENE$[/E2] and VEGFR-1 by immunohistochemistry.", "text_with_typed_entity_marker": "To assess clinical significance, 93 [DISEASE]@DISEASE$[/DISEASE] lesions were evaluated for expression of [GENE]@GENE$[/GENE] and VEGFR-1 by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [36, 45], "entity_1_idx_in_text_with_entity_marker": [40, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 54], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [87, 93], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_idx_in_text_with_typed_entity_marker": [112, 118], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_17", "text": "To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of VEGF and @GENE$ by immunohistochemistry.", "text_with_entity_marker": "To assess clinical significance, 93 [E1]@DISEASE$[/E1] lesions were evaluated for expression of VEGF and [E2]@GENE$[/E2] by immunohistochemistry.", "text_with_typed_entity_marker": "To assess clinical significance, 93 [DISEASE]@DISEASE$[/DISEASE] lesions were evaluated for expression of VEGF and [GENE]@GENE$[/GENE] by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [36, 45], "entity_1_idx_in_text_with_entity_marker": [40, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 54], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [96, 102], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_idx_in_text_with_typed_entity_marker": [121, 127], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_18", "text": "Expression of VEGFR-1 (@GENE$) in @DISEASE$ is associated with VEGF expression and with node-negative tumour stage.", "text_with_entity_marker": "Expression of VEGFR-1 ([E1]@GENE$[/E1]) in [E2]@DISEASE$[/E2] is associated with VEGF expression and with node-negative tumour stage.", "text_with_typed_entity_marker": "Expression of VEGFR-1 ([GENE]@GENE$[/GENE]) in [DISEASE]@DISEASE$[/DISEASE] is associated with VEGF expression and with node-negative tumour stage.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [34, 43], "entity_2_idx_in_text_with_entity_marker": [47, 56], "entity_2_idx_in_text_with_typed_entity_marker": [56, 65], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_19", "text": "Expression of VEGFR-1 (Flt-1) in @DISEASE$ is associated with @GENE$ expression and with node-negative tumour stage.", "text_with_entity_marker": "Expression of VEGFR-1 (Flt-1) in [E1]@DISEASE$[/E1] is associated with [E2]@GENE$[/E2] expression and with node-negative tumour stage.", "text_with_typed_entity_marker": "Expression of VEGFR-1 (Flt-1) in [DISEASE]@DISEASE$[/DISEASE] is associated with [GENE]@GENE$[/GENE] expression and with node-negative tumour stage.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [33, 42], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_idx_in_text_with_typed_entity_marker": [42, 51], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [62, 68], "entity_2_idx_in_text_with_entity_marker": [75, 81], "entity_2_idx_in_text_with_typed_entity_marker": [87, 93], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_20", "text": "@GENE$ was expressed in 60% and VEGFR-1 in 39% of @DISEASE$ specimens.", "text_with_entity_marker": "[E1]@GENE$[/E1] was expressed in 60% and VEGFR-1 in 39% of [E2]@DISEASE$[/E2] specimens.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] was expressed in 60% and VEGFR-1 in 39% of [DISEASE]@DISEASE$[/DISEASE] specimens.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [50, 59], "entity_2_idx_in_text_with_entity_marker": [63, 72], "entity_2_idx_in_text_with_typed_entity_marker": [72, 81], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_21", "text": "VEGF was expressed in 60% and @GENE$ in 39% of @DISEASE$ specimens.", "text_with_entity_marker": "VEGF was expressed in 60% and [E1]@GENE$[/E1] in 39% of [E2]@DISEASE$[/E2] specimens.", "text_with_typed_entity_marker": "VEGF was expressed in 60% and [GENE]@GENE$[/GENE] in 39% of [DISEASE]@DISEASE$[/DISEASE] specimens.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [30, 36], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_idx_in_text_with_typed_entity_marker": [36, 42], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [47, 56], "entity_2_idx_in_text_with_entity_marker": [60, 69], "entity_2_idx_in_text_with_typed_entity_marker": [69, 78], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_22", "text": "Vascular endothelial growth factor (@GENE$) promotes @DISEASE$ progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.", "text_with_entity_marker": "Vascular endothelial growth factor ([E1]@GENE$[/E1]) promotes [E2]@DISEASE$[/E2] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.", "text_with_typed_entity_marker": "Vascular endothelial growth factor ([GENE]@GENE$[/GENE]) promotes [DISEASE]@DISEASE$[/DISEASE] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [36, 42], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_idx_in_text_with_typed_entity_marker": [42, 48], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [53, 62], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_idx_in_text_with_typed_entity_marker": [75, 84], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_23", "text": "Vascular endothelial growth factor (VEGF) promotes @DISEASE$ progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (@GENE$) expressed on tumour cells.", "text_with_entity_marker": "Vascular endothelial growth factor (VEGF) promotes [E1]@DISEASE$[/E1] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 ([E2]@GENE$[/E2]) expressed on tumour cells.", "text_with_typed_entity_marker": "Vascular endothelial growth factor (VEGF) promotes [DISEASE]@DISEASE$[/DISEASE] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 ([GENE]@GENE$[/GENE]) expressed on tumour cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [51, 60], "entity_1_idx_in_text_with_entity_marker": [55, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 69], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [199, 205], "entity_2_idx_in_text_with_entity_marker": [212, 218], "entity_2_idx_in_text_with_typed_entity_marker": [224, 230], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_24", "text": "Our objective was to determine whether variants in the @GENE$ gene are associated with @DISEASE$ in the Japanese population.", "text_with_entity_marker": "Our objective was to determine whether variants in the [E1]@GENE$[/E1] gene are associated with [E2]@DISEASE$[/E2] in the Japanese population.", "text_with_typed_entity_marker": "Our objective was to determine whether variants in the [GENE]@GENE$[/GENE] gene are associated with [DISEASE]@DISEASE$[/DISEASE] in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [55, 61], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_idx_in_text_with_typed_entity_marker": [61, 67], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_25", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the @GENE$ in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the [E1]@GENE$[/E1] in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the [GENE]@GENE$[/GENE] in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [111, 117], "entity_1_idx_in_text_with_entity_marker": [115, 121], "entity_1_idx_in_text_with_typed_entity_marker": [117, 123], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_26", "text": "The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the @GENE$ in the susceptibility to acute-onset and other forms of @DISEASE$ in the Japanese population.", "text_with_entity_marker": "The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the [E1]@GENE$[/E1] in the susceptibility to acute-onset and other forms of [E2]@DISEASE$[/E2] in the Japanese population.", "text_with_typed_entity_marker": "The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the [GENE]@GENE$[/GENE] in the susceptibility to acute-onset and other forms of [DISEASE]@DISEASE$[/DISEASE] in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [129, 135], "entity_1_idx_in_text_with_entity_marker": [133, 139], "entity_1_idx_in_text_with_typed_entity_marker": [135, 141], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [192, 201], "entity_2_idx_in_text_with_entity_marker": [205, 214], "entity_2_idx_in_text_with_typed_entity_marker": [214, 223], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_27", "text": "We found evidence of association with acute-onset, but not slow-onset and fulminant, @DISEASE$ for two of the four single-nucleotide polymorphisms genotyped (rs706778 and @GENE$).", "text_with_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [E1]@DISEASE$[/E1] for two of the four single-nucleotide polymorphisms genotyped (rs706778 and [E2]@GENE$[/E2]).", "text_with_typed_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [DISEASE]@DISEASE$[/DISEASE] for two of the four single-nucleotide polymorphisms genotyped (rs706778 and [GENE]@GENE$[/GENE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [171, 177], "entity_2_idx_in_text_with_entity_marker": [184, 190], "entity_2_idx_in_text_with_typed_entity_marker": [196, 202], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_28", "text": "We found evidence of association with acute-onset, but not slow-onset and fulminant, @DISEASE$ for two of the four single-nucleotide polymorphisms genotyped (@GENE$ and rs3118470).", "text_with_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [E1]@DISEASE$[/E1] for two of the four single-nucleotide polymorphisms genotyped ([E2]@GENE$[/E2] and rs3118470).", "text_with_typed_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [DISEASE]@DISEASE$[/DISEASE] for two of the four single-nucleotide polymorphisms genotyped ([GENE]@GENE$[/GENE] and rs3118470).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [158, 164], "entity_2_idx_in_text_with_entity_marker": [171, 177], "entity_2_idx_in_text_with_typed_entity_marker": [183, 189], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "test_8_29", "text": "@GENE$ protein is an extracellular matrix molecule initially cloned from human @DISEASE$ cells treated with TGF-beta.", "text_with_entity_marker": "[E1]@GENE$[/E1] protein is an extracellular matrix molecule initially cloned from human [E2]@DISEASE$[/E2] cells treated with TGF-beta.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] protein is an extracellular matrix molecule initially cloned from human [DISEASE]@DISEASE$[/DISEASE] cells treated with TGF-beta.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [79, 88], "entity_2_idx_in_text_with_entity_marker": [92, 101], "entity_2_idx_in_text_with_typed_entity_marker": [101, 110], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_30", "text": "Polymorphisms in the regulatory region of the @GENE$ gene influence the susceptibility for HIV-1 @DISEASE$.", "text_with_entity_marker": "Polymorphisms in the regulatory region of the [E1]@GENE$[/E1] gene influence the susceptibility for HIV-1 [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Polymorphisms in the regulatory region of the [GENE]@GENE$[/GENE] gene influence the susceptibility for HIV-1 [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_31", "text": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of @GENE$ (CypA) and susceptibility to both HIV-1 @DISEASE$ and disease progression.", "text_with_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of [E1]@GENE$[/E1] (CypA) and susceptibility to both HIV-1 [E2]@DISEASE$[/E2] and disease progression.", "text_with_typed_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of [GENE]@GENE$[/GENE] (CypA) and susceptibility to both HIV-1 [DISEASE]@DISEASE$[/DISEASE] and disease progression.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [101, 107], "entity_1_idx_in_text_with_entity_marker": [105, 111], "entity_1_idx_in_text_with_typed_entity_marker": [107, 113], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [148, 157], "entity_2_idx_in_text_with_entity_marker": [161, 170], "entity_2_idx_in_text_with_typed_entity_marker": [170, 179], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_32", "text": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (@GENE$) and susceptibility to both HIV-1 @DISEASE$ and disease progression.", "text_with_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A ([E1]@GENE$[/E1]) and susceptibility to both HIV-1 [E2]@DISEASE$[/E2] and disease progression.", "text_with_typed_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A ([GENE]@GENE$[/GENE]) and susceptibility to both HIV-1 [DISEASE]@DISEASE$[/DISEASE] and disease progression.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [116, 122], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_idx_in_text_with_typed_entity_marker": [122, 128], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [157, 166], "entity_2_idx_in_text_with_entity_marker": [170, 179], "entity_2_idx_in_text_with_typed_entity_marker": [179, 188], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_33", "text": "No association of XRCC3 Thr241Met or @GENE$ and @DISEASE$ was found.", "text_with_entity_marker": "No association of XRCC3 Thr241Met or [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2] was found.", "text_with_typed_entity_marker": "No association of XRCC3 Thr241Met or [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE] was found.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [37, 43], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_idx_in_text_with_typed_entity_marker": [43, 49], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "test_8_34", "text": "DNA repair gene polymorphisms, such as those of @GENE$ and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to @DISEASE$.", "text_with_entity_marker": "DNA repair gene polymorphisms, such as those of [E1]@GENE$[/E1] and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "DNA repair gene polymorphisms, such as those of [GENE]@GENE$[/GENE] and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [138, 147], "entity_2_idx_in_text_with_entity_marker": [151, 160], "entity_2_idx_in_text_with_typed_entity_marker": [160, 169], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
